<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>2025-05-04 Nature Digest</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
            line-height: 1.6;
            max-width: 800px;
            margin: 0 auto;
            padding: 20px;
            color: #333;
        }
        h1 {
            color: #2c3e50;
            border-bottom: 2px solid #eee;
            padding-bottom: 10px;
        }
        .paper {
            margin-bottom: 30px;
            padding: 20px;
            background: #f8f9fa;
            border-radius: 5px;
        }
        .paper h2 {
            margin-top: 0;
            color: #2c3e50;
        }
        .paper a {
            color: #3498db;
            text-decoration: none;
        }
        .paper a:hover {
            text-decoration: underline;
        }
        .doi {
            color: #666;
            font-size: 0.9em;
        }
        .summary {
            margin-top: 10px;
            color: #444;
        }
        .journal {
            color: #666;
            font-style: italic;
            margin-bottom: 10px;
        }
    </style>
</head>
<body>
    <h1>2025-05-04 Nature Digest</h1>
    
    <div class="paper">
        <h2><a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(25)00424-3?rss=yes">Hepcidin and fungal infections: The liver fights back</a></h2>
        <div class="journal">Cell Reports</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">Arekar et al. discovered that the liver-derived peptide hepcidin can improve outcomes in invasive Candida albicans infections by reducing kidney iron availability and preventing renal damage. This finding reveals hepcidin agonists as a promising therapeutic approach to protect against fungal infections through targeted modulation of iron homeostasis.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(25)00443-7?rss=yes">ER-PM tether Syt1 limits cell-to-cell connectivity via plasmodesmata during innate immune responses in Arabidopsis</a></h2>
        <div class="journal">Cell Reports</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">Li et al. discovered that the ER-PM tether protein Syt1 regulates MAMP-induced plasmodesmata (PD) closure by sensing PI(4,5)P2 levels and interacting with ANN4 to activate PD-associated calcium signaling, leading to callose deposition at PDs. This finding reveals a novel mechanism by which plants limit cell-to-cell connectivity during innate immune responses, enhancing our understanding of how intercellular communication is modulated to restrict pathogen spread.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/179262">Long noncoding RNA BCYRN1 promotes cardioprotection by enhancing human and murine regulatory T cell dynamics</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study identifies the long noncoding RNA BCYRN1 within cardiosphere-derived cell extracellular vesicles as a critical enhancer of regulatory T cell proliferation, migration, and IL-10 production by sponging specific microRNAs, thereby promoting cardioprotection after myocardial infarction. These findings reveal BCYRN1 as a novel therapeutic target to boost Treg activity, offering potential benefits not only for ischemic heart injury but also for other conditions where enhancing Treg function is desired.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/183607">Restoring mitochondrial function promotes hematopoietic reconstitution from cord blood following cryopreservation-related functional decline</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study reveals that cryopreservation impairs umbilical cord blood hematopoietic stem and progenitor cells by disrupting mitochondrial function, leading to decreased hematopoietic reconstitution capacity, which can be restored by sulforaphane treatment. This finding advances understanding of cryopreservation-induced functional decline and offers a novel strategy to enhance the clinical utility and longevity of stored cord blood for transplantation.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188351">The complement system and kidney cancer: pathogenesis to clinical applications</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This review reveals that the complement system, beyond its traditional immune roles, actively regulates kidney cancer progression by modulating the tumor microenvironment, cell signaling, and immune responses. This insight underscores the therapeutic potential of targeting complement pathways, paving the way for novel immunotherapies and combination treatments to overcome kidney cancer resistance and improve patient outcomes.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184095">Mycobacterium tuberculosis hijacks the UBE2O pathway to regulate host iron homeostasis</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">The study reveals that Mycobacterium tuberculosis exploits the host UBE2O pathway to manipulate iron homeostasis during infection. This novel mechanism underscores a critical bacterial strategy to secure essential nutrients, offering potential targets for therapeutic intervention against tuberculosis.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/193824">Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study discovers that crystal deposition in kidney tubules induces their dilation, which in turn accelerates cyst formation in polycystic kidney disease. This finding reveals a novel pathological mechanism linking crystal buildup to disease progression, offering potential new targets for therapeutic intervention.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/192422">Biallelic OSM deficiency presents with juvenile myelodysplastic syndrome and response to treatment</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study identifies biallelic OSM deficiency as a cause of juvenile myelodysplastic syndrome, revealing a novel genetic basis for this early-onset bone marrow disorder. The findings underscore the potential for targeted therapeutic interventions in patients with OSM-related hematopoietic dysfunction.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/183099">Proteostasis and metabolic dysfunction characterize a subset of storage-induced senescent erythrocytes targeted for posttransfusion clearance</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">The study identifies storage-induced microerythrocytes (CFSEhi RBCs) as a distinct subset of senescent red blood cells characterized by metabolic depletion, irreversible protein oxidation, proteostasis disruption, and increased clearance from circulation. This delineation of molecular and cellular alterations in aged RBCs advances understanding of storage lesions and could inform strategies to improve transfusion outcomes by selectively targeting clearance-prone cells.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188352">Complement’s involvement in allergic Th2 immunity: a cross-barrier perspective</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study reveals that the complement system, especially components C3 and C5, plays a crucial role in driving Th2-polarized allergic responses across multiple barrier sites including the skin, gut, and respiratory tract. These findings provide novel insight into the common immunopathological mechanisms underlying diverse allergic diseases, highlighting potential targets for broad therapeutic intervention.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/174233">Weight loss in MASLD restores the balance of liver fatty acid sources</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study found that a 10% weight loss in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) significantly reduces intrahepatic triacylglycerol by markedly decreasing hepatic lipogenesis without altering free fatty acid or dietary fat contributions. These findings emphasize the central role of lipogenesis in MASLD pathology and suggest that targeting this pathway is critical for effective treatment strategies.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/192414">GLP-1 receptor agonists for the treatment of alcohol use disorder</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">GLP-1 receptor agonists (GLP-1RAs), but not DPP-4 inhibitors, were shown to reduce alcohol consumption in both humans and rodent models. This discovery reveals a novel therapeutic potential for GLP-1RAs as an early harm-reduction strategy in the treatment of alcohol use disorder.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/179572">AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study reveals that AMPK is essential for regulatory T cells to adapt their mitochondrial metabolism and maintain functional activity within metabolically stressed microenvironments such as tumors and viral pneumonia. This discovery highlights AMPK’s critical role in linking energy homeostasis to epigenetic regulation, providing new therapeutic avenues to modulate immune responses in cancer and inflammatory tissue injury.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184964">Tumor-specific surface marker–independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study presents a nanoparticle-based, tumor-specific surface marker–independent (TRACER) targeting strategy that selectively labels tumors with azide groups to enhance delivery and efficacy of anti–4-1BB immunotherapy. This approach significantly improves therapeutic outcomes by increasing tumor immune cell infiltration and reducing liver toxicity, overcoming challenges of limited tumor markers and off-target effects in cancer treatment.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184431">Inborn errors of immunity underlie clonal T cell expansions in large granular lymphocyte leukemia</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study identifies that clonal expansions of cytotoxic T lymphocytes in T cell large granular lymphocyte leukemia (T-LGLL) are frequently underpinned by rare germline variants associated with inborn errors of immunity (IEI), revealing a hidden immunodeficiency component in the disease. These findings challenge the conventional view of T-LGLL solely as an autoimmune or gain-of-function STAT3 mutation-driven disorder, expanding the understanding of its pathogenesis to include cryptic immunodeficiency and its links to clonal hematopoiesis and bone marrow failure.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188353">Chronic kidney disease enhances alternative pathway activity: a new paradigm</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This paper identifies that chronic kidney disease (CKD) enhances the activity of the alternative complement pathway by increasing factor D and altering pathway protein balance, thereby promoting systemic and vascular inflammation. This novel understanding highlights the alternative pathway as a potential therapeutic target to mitigate inflammation-driven cardiovascular and kidney disease progression in CKD patients.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/191907">The differential effects of sex hormone therapy on kidney function: insights into biological sex differences</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">Van Eeghen et al. demonstrate that feminizing hormone therapy with estrogen is renoprotective, whereas masculinizing therapy with testosterone adversely affects kidney function in transgender individuals. These findings underscore the biological impact of sex hormones on renal physiology and highlight the need for further research on hormone effects across diverse populations and life stages.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/186673">TET2 suppresses vascular calcification by forming an inhibitory complex with HDAC1/2 and SNIP1 independent of demethylation</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study reveals that TET2 suppresses vascular calcification by forming an inhibitory complex with HDAC1/2 and SNIP1 to repress RUNX2 transcription through histone deacetylation, independent of its DNA demethylation activity. This novel mechanism highlights TET2 as a potential therapeutic target for preventing vascular calcification in chronic kidney disease and related conditions.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/182709">CXCL12+ fibroblastic reticular cells in lymph nodes facilitate immune tolerance by regulating T cell–mediated alloimmunity</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">The study identifies a distinct subset of CXCL12hi fibroblastic reticular cells (FRCs) in lymph nodes that regulate alloimmune responses by producing immunoregulatory factors and promoting immune tolerance in heart transplantation. This finding reveals the critical role of CXCL12+ FRCs in fostering transplant tolerance and suggests their therapeutic potential for improving allograft survival through targeted modulation of the lymph node microenvironment.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/187711">Macrophage-mediated IL-6 signaling drives ryanodine receptor–2 calcium leak in postoperative atrial fibrillation</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study identifies that infiltrating CCR2+ macrophages promote postoperative atrial fibrillation (poAF) through IL-6-driven activation of the STAT3-CaMKII pathway, leading to ryanodine receptor–2 calcium leak in atrial cardiomyocytes. These findings reveal a novel macrophage-mediated molecular mechanism underlying poAF and suggest targeted inhibition of IL-6-STAT3-CaMKII signaling as a promising therapeutic strategy to prevent this common arrhythmia after cardiac surgery.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188743">Differential aortic aneurysm formation provoked by chemogenetic oxidative stress</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">The study demonstrates that chemogenetically induced oxidative stress in endothelial cells causes abdominal but not thoracic aortic aneurysms through region-specific dephosphorylation of JNK1 by DUSP3, activating KLF4-dependent pathways. This reveals distinct vascular bed responses to oxidative stress and identifies DUSP3 inhibition as a promising therapeutic strategy for preventing aortic aneurysm formation.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/184659">IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study identifies IL-33 as a crucial factor for protecting against recurrent Clostridioides difficile infection by promoting anti-TcdB antibody production through ST2+ ILC2 cell-mediated support of germinal center T follicular helper cells. These findings reveal a novel immunological mechanism wherein IL-33-driven humoral immunity prevents CDI recurrence, offering a potential target for enhancing patient outcomes.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188355">The multiverse of CD46 and oncologic interactions</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">CD46, originally known as a complement regulator, is now recognized for its diverse roles including modulation of immune responses, functioning as a receptor for various pathogens, and notably its involvement in cancer progression and metastasis. This multifaceted profile has propelled CD46 as a promising target for innovative cancer therapies, such as viral vector-based treatments and antibody-drug conjugates, underscoring its therapeutic potential across multiple oncologic contexts.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188533">Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study found that both naive and memory CD4+ T cells in children on long-term antiretroviral therapy harbor clonally expanded, intact HIV proviruses with distinct integration site profiles. This reveals that infected memory T cell clones rarely derive from naive cells in perinatally infected children, highlighting separate reservoirs that complicate HIV persistence despite early ART.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/188314">Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), but not dipeptidyl peptidase-4 inhibitors (DPP-4Is), significantly reduce alcohol consumption in humans and animal models. These results highlight the potential of GLP-1RAs as effective treatments for alcohol use disorder, offering a novel pharmacological avenue for intervention.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/190850">Unveiling mechanisms underlying kidney function changes during sex hormone therapy</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study demonstrates that feminizing hormone therapy with estradiol enhances measured kidney function and reduces tubular injury biomarkers, whereas masculinizing testosterone therapy shows opposing effects without changing glomerular filtration. These findings uncover sex hormone-driven mechanisms underlying kidney physiology differences and propose hormone-targeted strategies for sex-specific kidney disease management.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/187063">Activin A activation of Smad3 mitigates innate inflammation in mouse models of psoriasis and sepsis</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study discovered that activin A activates Smad3 phosphorylation in macrophages independently of TGF-β, triggering an anti-inflammatory pathway by regulating mitochondrial ATP and its conversion to adenosine. This novel activin A/Smad3 signaling axis serves as a natural brake on inflammation, with its disruption leading to worsened sepsis outcomes and psoriasis in mouse models.</div>
    </div>
    
    <div class="paper">
        <h2><a href="https://www.jci.org/articles/view/173354">Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice</a></h2>
        <div class="journal">Journal of Clinical Investigation</div>
        <div class="doi">DOI: 10.placeholder-20250504000228</div>
        <div class="summary">This study discovers that collagen type VI deficiency in skeletal muscle disrupts the regulation of TGF-β bioavailability, leading to early dysregulation of the TGF-β pathway in a mouse model of collagen VI–related muscular dystrophies. This novel mechanistic link between extracellular matrix composition and TGF-β signaling offers a potential therapeutic target for treating these dystrophies by restoring proper TGF-β regulation.</div>
    </div>
    
</body>
</html>